TY - JOUR
T1 - Intrinsic mechanical behavior of femoral cortical bone in young, osteoporotic and bisphosphonate-treated individuals in low-and high energy fracture conditions
AU - Zimmermann, Elizabeth A.
AU - Schaible, Eric
AU - Gludovatz, Bernd
AU - Schmidt, Felix N.
AU - Riedel, Christoph
AU - Krause, Matthias
AU - Vettorazzi, Eik
AU - Acevedo, Claire
AU - Hahn, Michael
AU - Puschel, Klaus
AU - Tang, Simon
AU - Amling, Michael
AU - Ritchie, Robert O.
AU - Busse, Bjorn
N1 - Funding Information:
Dr. Zimmermann is supported through a postdoctoral fellowship from the Alexander von Humboldt Foundation. Dr. Busse is supported by the DFG-Emmy Noether program under grant no. BU 2562/2-1 and PIER under grant no. PIF-2015-43. We acknowledge the use of the x-ray synchrotron beamline 7.3.3 (SAXS/WAXD) at the Advanced Light Source (ALS) at Lawrence Berkeley National Laboratory, which is funded by the Office of Science of the U.S. Department of Energy under contract no. DE-AC02-05CH11231. We acknowledge travel grants provided by the International Affairs, Strategy and Partnership office of the University of Hamburg. Grant Supporters: DFG - Deutsche Forschungsgemeinschaft (German Research Foundation); Alexander von Humboldt Foundation; Office of Science, U.S. Department of Energy; PIER–Partnership for Innovation, Education and Research, Nanosciences program.
PY - 2016/2/16
Y1 - 2016/2/16
N2 - Bisphosphonates are a common treatment to reduce osteoporotic fractures. This treatment induces osseous structural and compositional changes accompanied by positive effects on osteoblasts and osteocytes. Here, we test the hypothesis that restored osseous cell behavior, which resembles characteristics of younger, healthy cortical bone, leads to improved bone quality. Microarchitecture and mechanical properties of young, treatment-naive osteoporosis, and bisphosphonate-treated cases were investigated in femoral cortices. Tissue strength was measured using three-point bending. Collagen fibril-level deformation was assessed in non-traumatic and traumatic fracture states using synchrotron small-angle X-ray scattering (SAXS) at low and high strain rates. The lower modulus, strength and fibril deformation measured at low strain rates reflects susceptibility for osteoporotic low-energy fragility fractures. Independent of age, disease and treatment status, SAXS revealed reduced fibril plasticity at high strain rates, characteristic of traumatic fracture. The significantly reduced mechanical integrity in osteoporosis may originate from porosity and alterations to the intra/extrafibrillar structure, while the fibril deformation under treatment indicates improved nano-scale characteristics. In conclusion, losses in strength and fibril deformation at low strain rates correlate with the occurrence of fragility fractures in osteoporosis, while improvements in structural and mechanical properties following bisphosphonate treatment may foster resistance to fracture during physiological strain rates.
AB - Bisphosphonates are a common treatment to reduce osteoporotic fractures. This treatment induces osseous structural and compositional changes accompanied by positive effects on osteoblasts and osteocytes. Here, we test the hypothesis that restored osseous cell behavior, which resembles characteristics of younger, healthy cortical bone, leads to improved bone quality. Microarchitecture and mechanical properties of young, treatment-naive osteoporosis, and bisphosphonate-treated cases were investigated in femoral cortices. Tissue strength was measured using three-point bending. Collagen fibril-level deformation was assessed in non-traumatic and traumatic fracture states using synchrotron small-angle X-ray scattering (SAXS) at low and high strain rates. The lower modulus, strength and fibril deformation measured at low strain rates reflects susceptibility for osteoporotic low-energy fragility fractures. Independent of age, disease and treatment status, SAXS revealed reduced fibril plasticity at high strain rates, characteristic of traumatic fracture. The significantly reduced mechanical integrity in osteoporosis may originate from porosity and alterations to the intra/extrafibrillar structure, while the fibril deformation under treatment indicates improved nano-scale characteristics. In conclusion, losses in strength and fibril deformation at low strain rates correlate with the occurrence of fragility fractures in osteoporosis, while improvements in structural and mechanical properties following bisphosphonate treatment may foster resistance to fracture during physiological strain rates.
UR - http://www.scopus.com/inward/record.url?scp=84958279830&partnerID=8YFLogxK
U2 - 10.1038/srep21072
DO - 10.1038/srep21072
M3 - Article
C2 - 26879146
AN - SCOPUS:84958279830
SN - 2045-2322
VL - 6
JO - Scientific reports
JF - Scientific reports
M1 - 21072
ER -